Oral cancer rates are climbing and your toothbrush might be your best defense
When most people sit down with their dentist, the conversation usually drifts toward cavities or the state of their gums. But there is a growing threat that deserves far more attention, one that has been quietly climbing for the past two decades. Oral cancer now affects an estimated 60,000 Americans each year, and many people […]
Cancer prevention has 5 findings that explain why daily habits matter more than most people are told
Cancer prevention is the health conversation that most people approach as though it is primarily a matter of luck, genetics, and avoiding the obvious. Do not smoke. Wear sunscreen. Hope for the best. The research supporting this framework is real as far as it goes, and it does not go nearly far enough to capture […]
Cancer screenings that could seriously save your life
Early detection remains the most powerful weapon against cancer — and far too many people are skipping it. Cancer does not always announce itself. No dramatic pain, no obvious warning sign — just silence, and then a diagnosis that changes everything. That is exactly why screening exists, and exactly why skipping it can be deadly. […]
Lung cancer is the silent killer hiding behind a symptom you probably already have an excuse for
It does not get the same cultural attention as breast cancer or the same awareness campaigns as prostate cancer, but lung cancer quietly claims more American lives each year than both of those diseases combined, along with colon cancer. According to the American Cancer Society, no other cancer kills more people in the United States […]
Gas hobs and cancer risk are more connected than most home cooks realize
Most people assume their gas hob is only a concern when it is actively burning. New research suggests the greater risk may come when the appliance is completely off. A small but notable study found that close to one in 10 homes with gas hobs in the United Kingdom have leaks even in standby mode, […]
Merck $5.7bn deal targets bone and blood cancer
Merck is making yet another major move in the pharmaceutical world. The New Jersey-based drugmaker has agreed to acquire Terns Pharmaceuticals, a California-based biotech developing a promising treatment for a rare and life-threatening form of blood and bone cancer and the deal is worth $5.7 billion. The announcement, made Wednesday, signals just how aggressively Merck […]